PLYMOUTH MEETING, Pa.,
June 30, 2021 /PRNewswire/ -- ECRI,
an independent, nonprofit health services organization that
provides technology solutions and evidence-based guidance to
healthcare decision-makers worldwide, has been chosen to develop
the first large-scale International Horizon Scanning Database of
new and promising pharmaceutical products. The contract was awarded
by the International Horizon Scanning Initiative (IHSI), a
multi-nation European group.
ECRI's independence, evidence-based approach, and advanced use
of technology make ECRI an ideal partner.
Under the terms of the multi-year contract, ECRI will develop,
curate, and maintain a database of pharmaceuticals expected to
enter the European market within the next two and a half years.
ECRI will also create IHSI High Impact Reports which will provide
critical insights and information about new medications that show
highest potential to disrupt the market.
Both the database and High Impact Reports are expected to level
the playing field for stakeholders involved in the decision-making
process for the pricing and reimbursement of pharmaceuticals, and
may consequently aid potential price negotiations.
"By applying our deep expertise and unbiased objectivity, ECRI
will build a high-quality system that IHSI can rely on for the most
accurate understanding of the future impact of healthcare
technology and drugs," says Marcus
Schabacker, MD, PhD, president and chief executive officer
of ECRI. "We look forward to improving access to innovative, safe,
and effective medicines for millions of people worldwide."
ECRI is uniquely qualified to provide horizon scanning services
due to its current work with the Patient Centered Outcomes Research
Institute (PCORI) and previous work with the Agency for Healthcare
Research and Quality (AHRQ) to build and maintain the first U.S.
Healthcare Horizon Scanning System.
ECRI brings significant experience in assessing new treatment
models, procedures, and technologies with potential to cause
significant disruptions in one or more areas of healthcare. ECRI
has a track record of building high-quality healthcare information
systems and has worked with government agencies, medical
associations, and industry bodies since 1968. ECRI serves more than
5,000 customers worldwide.
"ECRI's independence, evidence-based approach, and advanced use
of data science, artificial intelligence, and technology make ECRI
an ideal partner," says Marcus
Guardian, general manager, IHSI.
The Belgium-based IHSI launched
in 2019 with the aim of pooling resources into the large-scale
collection of data on upcoming pharmaceuticals. Eight European
countries, representing 73 million people have committed to
supporting IHSI, and there is significant interest from several
nations further afield. Within these eight countries, national
expert bodies collaborate to make IHSI the key vendor of open
source, reliable data to support informed decision-making.
To learn more about ECRI and the International Horizon Scanning
Database, visit www.ecri.org, or contact ECRI at 610-825-6000 or
communications@ecri.org.
Social Sharing
- [NEWS] @ECRI_Org selected to develop first International
Horizon Scanning data repository of promising new
pharmaceuticals
About ECRI
ECRI is an independent, nonprofit
organization improving the safety, quality, and cost-effectiveness
of care across all healthcare settings. With a focus on patient
safety, evidence-based medicine, and health technology decision
solutions, ECRI is respected and trusted by healthcare leaders and
agencies worldwide.
Over the past fifty years, ECRI has built its reputation on
integrity and disciplined rigor, with an unwavering commitment to
independence and strict conflict-of-interest rules. ECRI is the
only organization worldwide to conduct independent medical device
evaluations, with labs located in North
America and Asia Pacific.
ECRI is designated an Evidence-based Practice Center by the U.S.
Agency for Healthcare Research and Quality. ECRI and the Institute
for Safe Medication Practices PSO is a federally certified Patient
Safety Organization as designated by the U.S. Department of Health
and Human Services. The Institute for Safe Medication Practices
(ISMP) formally became an ECRI Affiliate in 2020.
Visit www.ecri.org and follow @ECRI_Org.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ecri-chosen-by-international-horizon-scanning-initiative-ihsi-to-establish-groundbreaking-data-repository-of-promising-medicines-301322608.html
SOURCE ECRI